Virios Therapeutics Ownership 2024 | Who Owns Virios Therapeutics Now?

OverviewFinancials Chart Transcripts

Institutional Ownership

4.62%

Insider Ownership

6.74%

Retail Ownership

88.64%

Institutional Holders

20.00

Virios Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	1.08%	-	208,883	-	-	44,910	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.91%	-	174,469	-	-	37,516	Jun 30, 2024
UBS GROUP AG	0.79%	-	151,779	151,779	100.00%	32,632	Jun 30, 2024
HRT FINANCIAL LP	0.30%	0.00%	57,544	57,544	100.00%	12,000	Jun 30, 2024
MCCOLLUM CHRISTOFERSON GROUP LLC	0.30%	0.00%	57,000	15,000	35.71%	12,255	Jun 30, 2024
STATE STREET CORP	0.27%	-	52,828	-	-	11,358,000	Jun 30, 2024
XTX TOPCO LTD	0.22%	0.00%	42,650	42,650	100.00%	9,170	Jun 30, 2024
RAYMOND JAMES & ASSOCIATES	0.16%	-	30,000	-	-	6,450	Jun 30, 2024
NORTHERN TRUST CORP	0.12%	-	24,035	-	-	5,168,000	Jun 30, 2024
REGIONS FINANCIAL CORP	0.10%	-	20,072	-	-	4,315	Jun 30, 2024
MORGAN STANLEY	0.08%	-	15,000	-	-	3,225	Jun 30, 2024
VIRTU FINANCIAL LLC	0.06%	0.00%	11,850	11,850	100.00%	3,000	Jun 30, 2024
WILEY BROS.-AINTREE CAPITAL, LLC	0.06%	0.00%	11,000	-	-	2,365	Jun 30, 2024
WILLIAM HOWARD & CO FINANCIAL ADVISORS INC	0.05%	0.00%	10,072	-	-	2,000	Jun 30, 2024
ONE PLUS ONE WEALTH MANAGEMENT, LLC	0.05%	0.00%	10,000	10,000	100.00%	2,150	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	-	6,876	65	0.95%	1,478	Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT	0.02%	0.00%	3,000	3,000	100.00%	645	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.01%	-	1,297	-6,814	-84.01%	279,000	Jun 30, 2024
BLACKROCK INC.	0.00%	-	755	-	-	162	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	139	139	100.00%	30	Jun 30, 2024

Virios Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 1.08% of the company's total share outstanding, currently valued at $44.91K. The top 10 institutional shareholders own together 4.25% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MCCOLLUM CHRISTOFERSON GROUP LLC	0.30%	0.00%	57,000	15,000	35.71%	12,255	Jun 30, 2024
WILLIAM HOWARD & CO FINANCIAL ADVISORS INC	0.05%	0.00%	10,072	-	-	2,000	Jun 30, 2024
ONE PLUS ONE WEALTH MANAGEMENT, LLC	0.05%	0.00%	10,000	10,000	100.00%	2,150	Jun 30, 2024
XTX TOPCO LTD	0.22%	0.00%	42,650	42,650	100.00%	9,170	Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT	0.02%	0.00%	3,000	3,000	100.00%	645	Jun 30, 2024
VIRTU FINANCIAL LLC	0.06%	0.00%	11,850	11,850	100.00%	3,000	Jun 30, 2024
WILEY BROS.-AINTREE CAPITAL, LLC	0.06%	0.00%	11,000	-	-	2,365	Jun 30, 2024
HRT FINANCIAL LP	0.30%	0.00%	57,544	57,544	100.00%	12,000	Jun 30, 2024
REGIONS FINANCIAL CORP	0.10%	-	20,072	-	-	4,315	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	-	6,876	65	0.95%	1,478	Jun 30, 2024
UBS GROUP AG	0.79%	-	151,779	151,779	100.00%	32,632	Jun 30, 2024
RAYMOND JAMES & ASSOCIATES	0.16%	-	30,000	-	-	6,450	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.91%	-	174,469	-	-	37,516	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.01%	-	1,297	-6,814	-84.01%	279,000	Jun 30, 2024
NORTHERN TRUST CORP	0.12%	-	24,035	-	-	5,168,000	Jun 30, 2024
VANGUARD GROUP INC	1.08%	-	208,883	-	-	44,910	Jun 30, 2024
STATE STREET CORP	0.27%	-	52,828	-	-	11,358,000	Jun 30, 2024
MORGAN STANLEY	0.08%	-	15,000	-	-	3,225	Jun 30, 2024
BLACKROCK INC.	0.00%	-	755	-	-	162	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	139	139	100.00%	30	Jun 30, 2024

The largest Virios Therapeutics shareholder by % of total assets is MCCOLLUM CHRISTOFERSON GROUP LLC. The company owns 57.00K shares of Virios Therapeutics (VIRI), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	0.79%	-	151,779	151,779	100.00%	32,632	Jun 30, 2024
HRT FINANCIAL LP	0.30%	0.00%	57,544	57,544	100.00%	12,000	Jun 30, 2024
XTX TOPCO LTD	0.22%	0.00%	42,650	42,650	100.00%	9,170	Jun 30, 2024
MCCOLLUM CHRISTOFERSON GROUP LLC	0.30%	0.00%	57,000	15,000	35.71%	12,255	Jun 30, 2024
VIRTU FINANCIAL LLC	0.06%	0.00%	11,850	11,850	100.00%	3,000	Jun 30, 2024
ONE PLUS ONE WEALTH MANAGEMENT, LLC	0.05%	0.00%	10,000	10,000	100.00%	2,150	Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT	0.02%	0.00%	3,000	3,000	100.00%	645	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	139	139	100.00%	30	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	-	6,876	65	0.95%	1,478	Jun 30, 2024
BLACKROCK INC.	0.00%	-	755	-	-	162	Jun 30, 2024
MORGAN STANLEY	0.08%	-	15,000	-	-	3,225	Jun 30, 2024
STATE STREET CORP	0.27%	-	52,828	-	-	11,358,000	Jun 30, 2024
VANGUARD GROUP INC	1.08%	-	208,883	-	-	44,910	Jun 30, 2024
NORTHERN TRUST CORP	0.12%	-	24,035	-	-	5,168,000	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.91%	-	174,469	-	-	37,516	Jun 30, 2024
RAYMOND JAMES & ASSOCIATES	0.16%	-	30,000	-	-	6,450	Jun 30, 2024
REGIONS FINANCIAL CORP	0.10%	-	20,072	-	-	4,315	Jun 30, 2024
WILEY BROS.-AINTREE CAPITAL, LLC	0.06%	0.00%	11,000	-	-	2,365	Jun 30, 2024
WILLIAM HOWARD & CO FINANCIAL ADVISORS INC	0.05%	0.00%	10,072	-	-	2,000	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-133	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Virios Therapeutics's largest institutional buyer is UBS GROUP AG. The company purchased 151.78K stocks of VIRI, valued at $32.63K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GROUP ONE TRADING, L.P.	0.01%	-	1,297	-6,814	-84.01%	279,000	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-133	-100.00%	-	Jun 30, 2024
WILLIAM HOWARD & CO FINANCIAL ADVISORS INC	0.05%	0.00%	10,072	-	-	2,000	Jun 30, 2024
WILEY BROS.-AINTREE CAPITAL, LLC	0.06%	0.00%	11,000	-	-	2,365	Jun 30, 2024
REGIONS FINANCIAL CORP	0.10%	-	20,072	-	-	4,315	Jun 30, 2024
RAYMOND JAMES & ASSOCIATES	0.16%	-	30,000	-	-	6,450	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.91%	-	174,469	-	-	37,516	Jun 30, 2024
NORTHERN TRUST CORP	0.12%	-	24,035	-	-	5,168,000	Jun 30, 2024
VANGUARD GROUP INC	1.08%	-	208,883	-	-	44,910	Jun 30, 2024
STATE STREET CORP	0.27%	-	52,828	-	-	11,358,000	Jun 30, 2024
MORGAN STANLEY	0.08%	-	15,000	-	-	3,225	Jun 30, 2024
BLACKROCK INC.	0.00%	-	755	-	-	162	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	-	6,876	65	0.95%	1,478	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	139	139	100.00%	30	Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT	0.02%	0.00%	3,000	3,000	100.00%	645	Jun 30, 2024
ONE PLUS ONE WEALTH MANAGEMENT, LLC	0.05%	0.00%	10,000	10,000	100.00%	2,150	Jun 30, 2024
VIRTU FINANCIAL LLC	0.06%	0.00%	11,850	11,850	100.00%	3,000	Jun 30, 2024
MCCOLLUM CHRISTOFERSON GROUP LLC	0.30%	0.00%	57,000	15,000	35.71%	12,255	Jun 30, 2024
XTX TOPCO LTD	0.22%	0.00%	42,650	42,650	100.00%	9,170	Jun 30, 2024
HRT FINANCIAL LP	0.30%	0.00%	57,544	57,544	100.00%	12,000	Jun 30, 2024

As of Jun 30 2024, Virios Therapeutics's biggest institutional seller is GROUP ONE TRADING, L.P.. The company sold -6.81K shares of VIRI, valued at $279.00K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HRT FINANCIAL LP	0.30%	0.00%	57,544	57,544	100.00%	12,000	Jun 30, 2024
VIRTU FINANCIAL LLC	0.06%	0.00%	11,850	11,850	100.00%	3,000	Jun 30, 2024
ONE PLUS ONE WEALTH MANAGEMENT, LLC	0.05%	0.00%	10,000	10,000	100.00%	2,150	Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT	0.02%	0.00%	3,000	3,000	100.00%	645	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	139	139	100.00%	30	Jun 30, 2024

Virios Therapeutics's largest new institutional shareholder by number of shares is HRT FINANCIAL LP, purchased 57.54K shares, valued at $12.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-133	-100.00%	-	Jun 30, 2024

Virios Therapeutics's largest sold out institutional shareholder by shares sold is WELLS FARGO & COMPANY/MN, sold -0.13K shares, valued at -, as of undefined.

Virios Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	160,390	-683	-0.42%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	208,883	-208,883	-50.00%	Mar 31, 2024
Blackstone Alternative Investment Funds	0.00%	300	-	-	Mar 31, 2023
USAA MUTUAL FUNDS TRUST	0.00%	633	-	-	Jan 31, 2024
iSHARES TRUST	0.00%	38,500	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	1,339	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	639	-	-	Mar 31, 2024

Virios Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 160.39K shares, compromising 0.00% of its total assets.

Virios Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	20	-
31 Mar, 24	20	5.26%
31 Dec, 23	19	-13.64%
30 Sep, 23	22	-
30 Jun, 23	22	-
31 Mar, 23	22	-21.43%
31 Dec, 22	28	12.00%
30 Sep, 22	25	66.67%
30 Jun, 22	15	15.38%
31 Mar, 22	13	18.18%
31 Dec, 21	11	-8.33%
30 Sep, 21	12	-7.69%
30 Jun, 21	13	8.33%
31 Mar, 21	12	33.33%
31 Dec, 20	9	-

As of 30 Jun 24, 20 institutions are holding Virios Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	889,249	28.90%
31 Mar, 24	689,894	-19.79%
31 Dec, 23	860,147	5.01%
30 Sep, 23	819,117	6.83%
30 Jun, 23	766,733	-8.49%
31 Mar, 23	837,859	-35.56%
31 Dec, 22	1,300,197	1.04%
30 Sep, 22	1,286,825	13.38%
30 Jun, 22	1,134,960	3.63%
31 Mar, 22	1,095,197	15.40%
31 Dec, 21	949,019	-5.37%
30 Sep, 21	1,002,896	12.99%
30 Jun, 21	887,582	0.53%
31 Mar, 21	882,879	45.74%
31 Dec, 20	605,788	-

Virios Therapeutics (VIRI) has 889.25K shares outstanding as of 30 Jun 24, up 28.90% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	4.62%	34.21%
31 Mar, 24	3.67%	18.10%
31 Dec, 23	4.50%	22.76%
30 Sep, 23	4.45%	25.43%
30 Jun, 23	4.18%	20.02%
31 Mar, 23	4.57%	9.08%
31 Dec, 22	7.09%	3.63%
30 Sep, 22	13.99%	7.54%
30 Jun, 22	13.62%	7.88%
31 Mar, 22	13.15%	10.13%
31 Dec, 21	11.39%	7.86%
30 Sep, 21	12.04%	10.60%
30 Jun, 21	10.65%	9.48%
31 Mar, 21	10.60%	7.85%
31 Dec, 20	11.62%	-

As of 30 Jun 24, Virios Therapeutics is held by 4.62% institutional shareholders, representing a 34.21% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	9	12.50%
31 Mar, 24	8	33.33%
31 Dec, 23	6	-
30 Sep, 23	6	-57.14%
30 Jun, 23	14	55.56%
31 Mar, 23	9	-18.18%
31 Dec, 22	11	-35.29%
30 Sep, 22	17	112.50%
30 Jun, 22	8	14.29%
31 Mar, 22	7	16.67%
31 Dec, 21	6	-45.45%
30 Sep, 21	11	22.22%
30 Jun, 21	9	-18.18%
31 Mar, 21	11	22.22%
31 Dec, 20	9	-

9 institutional shareholders have increased their position in VIRI stock as of 30 Jun 24 compared to 8 in the previous quarter (a 12.50% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	1	-50.00%
31 Mar, 24	2	-
31 Dec, 23	2	-60.00%
30 Sep, 23	5	-
30 Jun, 23	5	-
31 Mar, 23	5	-44.44%
31 Dec, 22	9	-
30 Sep, 22	-	-100.00%
30 Jun, 22	2	-33.33%
31 Mar, 22	3	50.00%
31 Dec, 21	2	100.00%
30 Sep, 21	1	-66.67%
30 Jun, 21	3	200.00%
31 Mar, 21	1	-
31 Dec, 20	-	-

1 institutional shareholders have reduced their position in VIRI stock as of 30 Jun 24 compared to 2 in the previous quarter (a -50.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	20	-	889,249	28.90%	4.62%	34.21%	9	12.50%	1	-50.00%
31 Mar, 24	20	5.26%	689,894	-19.79%	3.67%	18.10%	8	33.33%	2	-
31 Dec, 23	19	-13.64%	860,147	5.01%	4.50%	22.76%	6	-	2	-60.00%
30 Sep, 23	22	-	819,117	6.83%	4.45%	25.43%	6	-57.14%	5	-
30 Jun, 23	22	-	766,733	-8.49%	4.18%	20.02%	14	55.56%	5	-
31 Mar, 23	22	-21.43%	837,859	-35.56%	4.57%	9.08%	9	-18.18%	5	-44.44%
31 Dec, 22	28	12.00%	1,300,197	1.04%	7.09%	3.63%	11	-35.29%	9	-
30 Sep, 22	25	66.67%	1,286,825	13.38%	13.99%	7.54%	17	112.50%	-	-100.00%
30 Jun, 22	15	15.38%	1,134,960	3.63%	13.62%	7.88%	8	14.29%	2	-33.33%
31 Mar, 22	13	18.18%	1,095,197	15.40%	13.15%	10.13%	7	16.67%	3	50.00%
31 Dec, 21	11	-8.33%	949,019	-5.37%	11.39%	7.86%	6	-45.45%	2	100.00%
30 Sep, 21	12	-7.69%	1,002,896	12.99%	12.04%	10.60%	11	22.22%	1	-66.67%
30 Jun, 21	13	8.33%	887,582	0.53%	10.65%	9.48%	9	-18.18%	3	200.00%
31 Mar, 21	12	33.33%	882,879	45.74%	10.60%	7.85%	11	22.22%	1	-
31 Dec, 20	9	-	605,788	-	11.62%	-	9	-	-	-

Virios Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Aug 22, 2023	Pridgen William	director	-	P-Purchase	Buy	15,335	$1.30	$19.99K	52,045
Aug 18, 2023	Duncan Gregory Scott	director, officer	CHIEF EXECUTIVE OFFICER	P-Purchase	Buy	25,000	$1.25	$31.25K	57,461

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Aug 22, 2023	Pridgen William	director	-	P-Purchase	Buy	15,335	$1.30	$19.99K	52,045
Aug 18, 2023	Duncan Gregory Scott	director, officer	CHIEF EXECUTIVE OFFICER	P-Purchase	Buy	25,000	$1.25	$31.25K	57,461

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 28, 2024	Pridgen William	director	-	A-Award	Buy	2,917	$0.36	$1.04K	2,917
Feb 28, 2024	Thomas John C	director	-	A-Award	Buy	4,167	$0.36	$1.49K	4,167
Feb 28, 2024	Whitley Richard James	director	-	A-Award	Buy	4,000	$0.36	$1.43K	4,000
Feb 28, 2024	Keefer David R	director	-	A-Award	Buy	4,709	$0.36	$1.68K	4,709
Feb 28, 2024	Burch Richard Alan	director	-	A-Award	Buy	2,917	$0.36	$1.04K	2,917
Feb 28, 2024	De La Rosa Abel	director	-	A-Award	Buy	3,959	$0.36	$1.41K	3,959
Feb 28, 2024	Walsh Angela	officer	SVP OF FINANCE	A-Award	Buy	63,618	$0.36	$22.71K	63,618
Feb 28, 2024	Grosswald Ralph	officer	SVP OF OPERATIONS	A-Award	Buy	62,568	$0.36	$22.34K	62,568
Feb 28, 2024	Gendreau Roger Michael	officer	CHIEF MEDICAL OFFICER	A-Award	Buy	88,085	$0.36	$31.45K	88,085
Feb 28, 2024	Duncan Gregory Scott	director, officer	CHIEF EXECUTIVE OFFICER	A-Award	Buy	138,835	$0.36	$49.56K	138,835
Aug 22, 2023	Pridgen William	director	-	P-Purchase	Buy	15,335	$1.30	$19.99K	52,045
Aug 18, 2023	Duncan Gregory Scott	director, officer	CHIEF EXECUTIVE OFFICER	P-Purchase	Buy	25,000	$1.25	$31.25K	57,461
Jun 20, 2023	Keefer David R	director	-	A-Award	Buy	5,250	$1.85	$9.71K	5,250
Jun 20, 2023	De La Rosa Abel	director	-	A-Award	Buy	5,250	$1.85	$9.71K	5,250
Jun 20, 2023	Thomas John C	director	-	A-Award	Buy	5,250	$1.85	$9.71K	5,250
Jun 20, 2023	Burch Richard Alan	director	-	A-Award	Buy	5,250	$1.85	$9.71K	5,250
Jun 20, 2023	Whitley Richard James	director	-	A-Award	Buy	5,250	$1.85	$9.71K	5,250
Jun 20, 2023	Pridgen William	director	-	A-Award	Buy	5,250	$1.85	$9.71K	5,250
Feb 15, 2023	Duncan Gregory Scott	director, officer	CHIEF EXECUTIVE OFFICER	A-Award	Buy	410,000	$0.28	$114.35K	410,000
Dec 14, 2022	Duncan Gregory Scott	director	CHIEF EXECUTIVE OFFICER	A-Award	Buy	480,000	-	-	480,000

The last insider buy of VIRI was made by Pridgen William on Aug 22 2023, buying 15,335 shares at $1.30 per share (worth $19.99K).

Virios Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	10	-	-
Q3 2023	2	-	-
Q2 2023	6	-	-
Q4 2022	5	1	500.00%
Q2 2022	21	-	-
Q1 2022	8	-	-
Q4 2021	3	1	300.00%
Q3 2021	1	-	-
Q2 2021	12	-	-
Q1 2021	9	3	300.00%
Q4 2020	4	6	66.67%

10 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Virios Therapeutics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q3 2023	2	-	-
Q2 2023	-	-	-
Q4 2022	-	1	-
Q2 2022	5	-	-
Q1 2022	8	-	-
Q4 2021	3	-	-
Q3 2021	1	-	-
Q2 2021	3	-	-
Q1 2021	2	-	-
Q4 2020	1	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Virios Therapeutics's stocks.

Virios Therapeutics Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
CNSP	CNS Pharmaceuticals, Inc.
ICU	SeaStar Medical Holding Corporation
PHIO	Phio Pharmaceuticals Corp.
REVB	Revelation Biosciences, Inc.
RNAZ	TransCode Therapeutics, Inc.
EFTR	eFFECTOR Therapeutics, Inc.
IMMX	Immix Biopharma, Inc.
CYTO	Altamira Therapeutics Ltd.
SONN	Sonnet BioTherapeutics Holdings, Inc.
ZURA	Zura Bio Limited

VIRI Ownership FAQ

Who Owns Virios Therapeutics?

Virios Therapeutics is owned by institutional shareholders (4.62%), insiders (6.74%), and public (88.64%). The largest institutional shareholder of Virios Therapeutics is VANGUARD GROUP INC (1.08% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of Virios Therapeutics?

Virios Therapeutics's major institutional shareholders are VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS GROUP AG, HRT FINANCIAL LP, and MCCOLLUM CHRISTOFERSON GROUP LLC. The top five shareholders own together 3.37% of the company's share outstanding.

How many Virios Therapeutics shareholders are there?

As of Jun 2024, there are 20 institutional shareholders of Virios Therapeutics.

What percentage of Virios Therapeutics is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC owns 208.88K shares of Virios Therapeutics, representing 1.08% of the company's total shares outstanding, valued at $44.91K (as of Jun 2024).

What percentage of Virios Therapeutics is owned by GEODE CAPITAL MANAGEMENT, LLC?

As of Jun 2024, GEODE CAPITAL MANAGEMENT, LLC holds 174.47K shares of Virios Therapeutics (VIRI), compromising 0.91% of the company, valued at $37.52K.

What percentage of Virios Therapeutics is owned by UBS GROUP AG?

UBS GROUP AG is the third largest holder of Virios Therapeutics. The company owns 151.78K of the company's shares outstanding (worth $32.63K).